海正生材（688203）披露股东减持股份结果公告，11月12日股价下跌0.67%

Core Viewpoint - The recent share reduction by a major shareholder, Sinopec Capital, indicates a strategic move to meet operational funding needs, which may impact investor sentiment and stock performance in the short term [1]. Group 1: Stock Performance - As of November 12, 2025, the stock of Zhejiang Haizheng Biomaterials Co., Ltd. (688203) closed at 13.33 yuan, down 0.67% from the previous trading day [1]. - The stock opened at 13.45 yuan, reached a high of 13.50 yuan, and a low of 13.19 yuan, with a trading volume of 28.59 million yuan and a turnover rate of 1.73% [1]. Group 2: Shareholder Actions - Sinopec Capital, holding over 5% of shares, reduced its stake by 2,026,700 shares, representing 1% of the total share capital, between October 28 and November 11, 2025 [1]. - The reduction occurred at a price range of 12.84 to 13.49 yuan per share, totaling approximately 26.73 million yuan [1]. - Post-reduction, Sinopec Capital holds 10,788,194 shares, accounting for 5.32% of the total share capital, consistent with the previously disclosed reduction plan [1].